Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Celltrion’s Remsima SC Will No Longer Need IV Loading
EMA Committee Endorses Direct Subcutaneous Use Of Infliximab Biosimilar
Mar 31 2021
•
By
David Wallace
No intravenous loading will be required ahead of subcutaneous administration • Source: Shutterstock
More from Biosimilars
More from Products